Tozaro specializes in cell and gene therapy bioprocessing by designing and manufacturing custom affinity ligands using smart polymers. The company combines in silico modeling, machine learning, and chemical synthesis to create ligands tailored to viral vectors and specific purification and analytics applications. Their approach enables faster, animal component–free ligand production for viral vector purification and enhanced analytics across opposing platforms. Based in England, Tozaro markets technologies such as viral vector analytics, purification, and advanced bioprocessing tools for the biopharma industry.
No recent news for this company.